Our Projects

We are developing a pipeline of small-molecule drugs to treat autoimmune diseases and cancer.

Our projects target key biological processes in the pathology of cancer and autoimmune diseases, including transcription, translation, and protein signaling.

Pipeline

discovery
preclinical
Phase I/II

Immunology | Best-in-class | Sanofi

RORγt
spacer

Oncology | First-in-class | LP

ERRα
spacer

Oncology | Best-in-class | LP

LXR
spacer

Oncology | Best-in-class | LP

PRMT5
spacer

Immunology | First-in-class | Roche

TH17
spacer

New targets | several | LP

several undisclosed
spacer